Hypertriglyceridemia During Anticancer Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia – A Nationwide Experience

Cancer Management and Research 2026 Open access

Read full text
Authors: Joanna Zawitkowska, Eryk Latoch, Katarzyna Karska, Katarzyna Drabko, Monika Lejman, Klaudia Paczóska, Tomasz Ociepa, Anna Malecka, Dorota Sęga-Pondel, Krzysztof Kalwak, Katarzyna Konończuk, Julia Kołodrubiec
+19 more Joanna Trelińska, Ewa Demidowicz, M Andrzejewska, Katarzyna Derwich, Zuzanna Zakrzewska, Szymon Pawel Skoczen, Agnieszka Mizia‐Malarz, Grażyna Karolczyk, Wioletta Bal, Radosław Chaber, Patrycja Tyszka, Wanda Badowska, Mariola Janiszewska, Jerzy Roman Kowalczyk, Wojciech Młynarski, Tomasz Szczepański, Jan Styczyński, Ninela Irga-Jaworska, Katarzyna Muszyńska‐Rosłan
DOI: 10.2147/cmar.s572651
Cited by: 1
References: 18

Abstract

Purpose: In this study, we aimed to assess the demographics and incidence of hypertriglyceridemia (HTG) during acute lymphoblastic leukemia (ALL) treatment, complications related to HTG, and the treatment strategies applied in pediatric patients treated in pediatric hemato-oncology centers in Poland. Patients and Methods: A total of 72 out of 641 children, aged

Fields of Study & Subjects

Pancreatitis Pathology and Treatment Acute Lymphoblastic Leukemia research Childhood Cancer Survivors' Quality of Life

Publication details

Journal / source
Cancer Management and Research
Publisher
Informa UK Limited
Volume
Volume 18
Pages
1–13
Publication date
1 February 2026
Language
EN